Idana | Updates

By Lucas Spohn

Idana Launches Marketing and Sales Campaign

Public
Public

Dear Companists,

Our minimal viable product has grown into a software solution that satisfies even demanding users: A modern design, intuitive user interface, and the link to all common medical information systems via GDT interface make Idana a powerful tool for physicians’ daily use.  

Now it’s time to bring our product to doctors. Therefore, we launched our marketing and sales campaign this week: We will present the challenges (and chances) associated with the sale of Idana and introduce you to our sales and marketing team in this update.

 

Challenge eHealth: Why things are sometimes more difficult for pioneers

Idana is an innovative product that is completely new to the German market in this form. Comparable systems gather data for research or offer digital educational forms. One would think that market penetration would be easy when there are no national and very few international competitors. However, sometimes things are more difficult for pioneers.

When software developers, who improve or advance existing solutions, address their customers, these usually already have an understanding of what to expect from the product. This simplifies the marketing and sales team’s work considerably: They already know who their potential customers are and how best to reach them.

It’s a bit different for Idana: Although personal experience and thorough market research have given us in-depth knowledge of clinics and doctor’s offices, physicians usually are unaware that software can support them in the routine process of anamnesis. Although every doctor has to consider which office management system he or she wants to use and actively looks for a suitable product, we still need to create awareness that Idana can truly make a difference in daily procedures. Our first customers will be pioneers – the task now is to find them and be sought out by them.

 

Kick-off meeting sales: Combining forces for market penetration

The writer Ralph Waldo Emerson once said that “every revolution was first a thought in one man’s mind.” Our revolution of the anamnesis process has successfully navigated this initial phase, now it’s time to transfer the thought to the minds of its protagonists.

In cooperation with our experienced sales experts Claus and Lilian, our marketing & sales manager, our team completed intensive coaching this week. We are now ready to expand our customer base and inspire the doctors of Idana with new product brochures.

 

Idana - Marketing Team

 

We were able to strengthen this motivated team thanks to your support, dear Companists. The mindset is right, the marketing and sales strategy is sound, and we firmly believe: We can do it!

 

Best greetings from Freiburg,
Lucas Spohn



Comments

Only registered Companists can comment. Please log in to leave a comment.

Note

Investments in crowdfunding projects offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, these investments are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by splitting their investment amount between crowdfunding campaigns rather than investing all of it in one crowdfunding campaign. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the Companists are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the Companists – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, crowdfunding investments are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 500,000

Invested

735

Companists

22.58 %

Share Offered

Please note
The acquisition of this asset involves considerable risks and can lead to the complete loss of the assets used.

Follow us

Contact Us
Your contact for all questions about investing on Companisto:
Sascha Jung
Investor Relations

Toll-free phone number for investors

0800 - 100 267 0 (DE)
0800 - 100 267(AT / CH)

Service hours Mo-Fr 9 a.m.- 7 p.m.

Companisto GmbH
Köpenicker Str. 154
10997 Berlin
Newsletter
Der E-Mail-Newsletter ist jederzeit mit einem Klick abbestellbar.
Source: Own research. Based on data from the German Private Equity and Venture Capital Association - BVK, among others.
Investor Support
Please register in order to see the complete profile of Idana.
Already registered?    Log in